Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Clinical trial NCT07569653 · RECRUITING

Trial details

NCT number: NCT07569653
Sponsor: WeiShi
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cytomegalovirus Infections Cytomegalovirus Disease Hematopoietic Stem Cell Transplantation Graft vs Host Disease

Start date: 2025-10-30
Primary completion: 2027-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.